United States Transfection Technologies Market by Product Type, Distribution Channel, End User 2023-2028

1
United States Transfection Technologies Market
Research and Forecast Report 2023-2028

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Transfection Technologies
  Market Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2023-2028," the United
  States transfection technologies market size
  reached US 359 Million in 2022.
• Transfection technology is a vital laboratory
  technique in molecular biology and biotechnology
  research. It introduces exogenous genetic
  material into eukaryotic cells, such as
  deoxyribonucleic acid (DNA) or ribonucleic acid
  (RNA), enabling scientists to study gene
  function, protein expression, cellular processes,
  and genetic modifications.
• It is utilized in various scientific fields,
  including gene function studies, protein
  expression for research or therapeutic purposes,
  disease research, cell line development, and drug
  screening. Transfection technology is applied to
  various cell types and biological systems
  allowing researchers to customize experiments by
  selecting specific genes or genetic elements to
  introduce into cells, and the technique offers
  both temporary and stable genetic modifications
  depending on the method used. The speed and
  efficiency of transfection allows for rapid
  manipulation of cell genetics, yielding quicker
  results than other genetic engineering
  approaches.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-transfect
  ion-technologies-market/requestsample

4
Report Description

• United States Transfection Technologies Market
  Trends
• The increasing demand for transfection technology
  as the understanding of genetics and molecular
  biology increases is one of the major factors
  driving the market growth. Additionally, the
  growing application of transfection technologies
  as researchers and biotechnologists rely on it to
  study gene function, protein expression, and
  cellular processes, leading to significant
  breakthroughs in various scientific fields, is
  creating a positive outlook for the market.
  Moreover, the rising prevalence of infectious
  diseases in the US, such as bacterial infections,
  necessitates the development of effective
  antibiotics enabling the introduction of
  antimicrobial genes or genetic constructs into
  cells to combat drug-resistant pathogens, is
  positively impacting the market growth. In
  addition to this, the growing application of
  these technologies for modifying cells before
  reintroducing them into patients, enhancing the
  therapeutic potential with cell-based therapies,
  such as CAR-T cell therapy, is supporting the
  market growth. Furthermore, rapid technological
  advancements in transfection methods and delivery
  systems that have made the process more
  efficient, reliable, and accessible are
  propelling the market growth. In line with this,
  the increasing utilization of these technologies
  in delivering therapeutic genes and molecules to
  target cancer cells and supporting precision
  medicine approaches tailored to individual
  patient profiles are providing remunerative
  growth opportunities. Besides this, the growing
  product popularity in the production of
  recombinant proteins used in therapeutic
  applications is favoring the market growth. Apart
  from this, the widespread application of
  transfection technology in the agricultural
  sector to engineer crops and improve their
  traits, such as disease resistance, nutritional
  content, and yield, and the increasing global
  demand for sustainable and enhanced crop
  production is providing a considerable boost to
  the market growth.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-transfect
  ion-technologies-market

5
Report Segmentation

• Breakup by Product Type
• Reagent
• Instrument
• Others
•  
• Breakup by Application
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others
• Breakup by Transfection Method
• Lipofection
• Electroporation
• Nucleofection
• Cotransfection
• Cationic Lipid Transfection
• In-Vivo Transfection

6
Report Segmentation

• Others
• Breakup by Technology
• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection
• Breakup by End User
• Research Centers and Academic Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others
• Breakup by Region
• Northeast
• Midwest
• South
• West

7
Key Questions Answered in the Report
8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    United States Transfection
  Technologies Market    5.1    Market Overview 
    5.2    Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product Type
•   6.1    Reagent    6.1.1 Market Trends   
     6.1.2 Market Forecast    6.2 Instrument 
    6.2.1  Market Trends       6.2.2 Market
  Forecast    6.3 Others    6.3.1 Market
  Trends       6.3.2 Market Forecast
• 7     Market Breakup by Application       

10
Table of Contents

• 7.1 Therapeutic Delivery
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Bio-Medical Research
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Protein Production
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Others
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 8  Market Breakup by Transfection Method
• 8.1 Lipofection
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Electroporation
• 8.2.1 Market Trends
• 8.2.2 Market Forecast

11
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

12
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com